According to our latest research, the global Enteric Coated Softgels For Consumer Health Spplements market size will reach USD 2550 million in 2031, growing at a CAGR of 3.9% over the analysis period.
An enteric softgel capsule is an oral drug delivery system encapsulated in a gelatin-based shell designed to release its contents in the small intestine rather than the stomach. The gelatin shell, which may include glycerin and plasticizers, is flexible and easy to swallow. This specific formulation prevents the premature release of the encapsulated substance, making it suitable for drugs or supplements sensitive to gastric acids. Enteric softgel capsules are commonly utilized in the pharmaceutical and nutraceutical industries, offering benefits such as enhanced drug absorption, reduced gastrointestinal side effects, and improved patient compliance, especially for individuals with specific health considerations.
The enteric softgel capsules industry is experiencing growth propelled by technological advancements in manufacturing. Ongoing innovations enhance the efficiency and precision of softgel capsule production, contributing to improved quality and cost-effectiveness. Key industry players are actively focusing on developing advanced manufacturing methodologies, emphasizing automation and novel techniques. For instance, Catalent, Inc, offers OptiGel DR Softgel Technology, that has the capability to deliver an enteric release profile in a single-step manufacturing process without the need for coating. This commitment to technological progress not only boosts production capabilities but also ensures a competitive edge in the market. The growing synergy between technological advancements and the strategic initiatives of key players underscores a positive trajectory for the enteric softgel capsule market, fostering increased reliability and innovation in the manufacturing process. In addition, the enteric softgel capsules industry is experiencing additional growth due to the increasing focus on clinical trials for new technologies and formulations. For instance, in October 2023, Evonik, a specialty chemicals leader, introduced EUDRACAP, a preclinical functional oral capsule. This enteric-coated capsule offers pharmaceutical companies a valuable tool in optimizing drug development during preclinical trials. By reducing costs, time, and variables, EUDRACAP enhances the efficiency of drug development processes. This innovative approach aligns with the industry's commitment to advancing methodologies, fostering a climate of continuous improvement and driving the market's growth through enhanced capabilities in clinical research and development.
This report is a detailed and comprehensive analysis for global Enteric Coated Softgels For Consumer Health Spplements market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enteric Coated Softgels For Consumer Health Spplements market size and forecasts, in consumption value ($ Million), 2020-2031
Global Enteric Coated Softgels For Consumer Health Spplements market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Enteric Coated Softgels For Consumer Health Spplements market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Enteric Coated Softgels For Consumer Health Spplements market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enteric Coated Softgels For Consumer Health Spplements
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enteric Coated Softgels For Consumer Health Spplements market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viva Pharmaceuticals, Fuji Capsules Co. Ltd, Aenova Group, Captek Softgel International Inc, Gelita AG, Procaps Group, InovoBiologic Inc, Catalent, Inc, Sirio Pharma Co., Ltd, NOW Foods Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Enteric Coated Softgels For Consumer Health Spplements market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Type-A Gelatin (Pork Skin)
Type-B Gelatin (Animal Bones & Skin)
Starch Material
Others
Market segment by Application
Online
Offline
Market segment by players, this report covers
Viva Pharmaceuticals
Fuji Capsules Co. Ltd
Aenova Group
Captek Softgel International Inc
Gelita AG
Procaps Group
InovoBiologic Inc
Catalent, Inc
Sirio Pharma Co., Ltd
NOW Foods Inc.
Renown Pharmaceuticals Pvt. Ltd.
Lonza Group Ltd
Basf SE
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Enteric Coated Softgels For Consumer Health Spplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Enteric Coated Softgels For Consumer Health Spplements, with revenue, gross margin, and global market share of Enteric Coated Softgels For Consumer Health Spplements from 2020 to 2025.
Chapter 3, the Enteric Coated Softgels For Consumer Health Spplements competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Enteric Coated Softgels For Consumer Health Spplements market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Enteric Coated Softgels For Consumer Health Spplements.
Chapter 13, to describe Enteric Coated Softgels For Consumer Health Spplements research findings and conclusion.
Summary:
Get latest Market Research Reports on Enteric Coated Softgels For Consumer Health Spplements. Industry analysis & Market Report on Enteric Coated Softgels For Consumer Health Spplements is a syndicated market report, published as Global Enteric Coated Softgels For Consumer Health Spplements Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Enteric Coated Softgels For Consumer Health Spplements market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.